Clinical efficacy of fibrinolytic enzyme combined with compound danshen injection in the treatment of encapsulated tuberculous pleurisy
返回论文页
|更新时间:2022-11-04
|
Clinical efficacy of fibrinolytic enzyme combined with compound danshen injection in the treatment of encapsulated tuberculous pleurisy
Health Medicine Research and PracticeVol. 19, Issue 4, Pages: 38-40(2022)
作者机构:
南阳医学高等专科学校第一附属医院感染科
作者简介:
基金信息:
DOI:
CLC:R521.7
Published:2022,
扫 描 看 全 文
Guo Chunxia, Yang Zhenhao, Wang Qi. Clinical efficacy of fibrinolytic enzyme combined with compound danshen injection in the treatment of encapsulated tuberculous pleurisy. [J]. Health Medicine Research and Practice 19(4):38-40(2022)
DOI:
Guo Chunxia, Yang Zhenhao, Wang Qi. Clinical efficacy of fibrinolytic enzyme combined with compound danshen injection in the treatment of encapsulated tuberculous pleurisy. [J]. Health Medicine Research and Practice 19(4):38-40(2022)DOI:
Clinical efficacy of fibrinolytic enzyme combined with compound danshen injection in the treatment of encapsulated tuberculous pleurisy
Objective To explore the clinical effects of fibrinolytic enzyme combined with compound danshen injection in the treatment of encapsulated tuberculous pleurisy. Methods Eighty cases of patients with encapsulated tuberculous pleurisy treated in a hospital in Nanyang from June 2018 to November 2020 were selected as study subjects and divided into observation and control groups using a random number table
with 40 cases in each group. The patients in the control group were treated with fibrinolytic enzyme injection
and the patients in the observation group were treated with compound danshen injection on the basis of the control group. The clinical efficacy
the disappearance time of pleural effusion
as well as pleural thickness and coagulation functions including prothrombin time(PT)
fibrinogen(FIB) level and thrombin time(TT) before and after the treatment were compared between the 2 groups. Results The total effective rate of treatment for patients in the observation group was 95.00%(38/40)
which was higher than that of 80.00%(32/40) in the control group
and the difference was statistically significant(χ~2=4.114
P=0.043). The disappearance time of pleural effusion was shorter in the observation group than in the control group
and the difference was statistically significant(t=7.240
P<0.001). The pleural thickness after treatment was smaller than before treatment in both groups
and it was smaller in the observation group than in the control group
with statistically significant differences(P<0.05). the FIB level after treatment was lower than before treatment in both groups
and it was lower in the observation group than in the control group
with statistically significant differences(P <0.05); the differences were not statistically significant(P>0.05) when comparing PT and TT after treatment in the 2 groups. Conclusion Fibrinolytic enzyme combined with compound danshen injection is effective in the treatment of encapsulated tuberculosis pleurisy
as it promotes the absorption of pleural effusion
reduces the thickness of pleura and improves the coagulation function of patients.
关键词
包裹性结核性胸膜炎复方丹参注射液纤溶酶胸腔积液消失时间胸膜厚度
Keywords
Encapsulated tuberculosis pleurisyCompound danshen injectionFibrinolytic enzymeDisappearance time of pleural effusionPleural thickness